Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Compound 4 is a promising treatment for hair loss with low toxicity.

Inclisiran is effective at lowering cholesterol.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Ritlecitinib can help about 14,000 people with severe hair loss.

CTP-543 is generally safe for treating alopecia areata.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.